Alzheon Announces Study to Evaluate ALZ-801 Effects on Alzheimer’s Biomarkers
editor The following is a press release submitted to SOURCE from its business wire service. *** FRAMINGHAM- Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering…